معرفی
Stephen Wheatcroft serves as Professor of Cardiometabolic Medicine at the University of Leeds' Faculty of Medicine and Health, where he holds dual leadership roles as Director of Research & Innovation for the School of Medicine and Head of the Discovery and Translational Science Department. An academic interventional cardiologist and vascular biologist, he leads research on insulin-like growth factor binding proteins in cardio-metabolic disease.
His educational background includes:
- BSc (Hons) and MBChB (Hons) from University of Birmingham (1994)
- PhD in Cardiovascular Medicine from King's College London (2000-2003)
- Clinical cardiology training at King's College Hospital London
- Visiting fellowships at Charles University (Prague) and Jagiellonian University (Kraków)
Wheatcroft's research spans basic vascular biology and clinical cardiology. His laboratory investigates insulin-like growth factor system mechanisms in endothelial function, atherosclerosis, and metabolic regulation, while his clinical work focuses on coronary physiology and acute coronary syndrome management. Recent publications reveal intensified exploration of endothelial-adipose tissue crosstalk, IGF receptor signaling, and translational interventions for diabetes complications and vascular disease. His group employs genetic models, human tissue studies, and clinical trial leadership to bridge molecular discoveries with patient care.
Award highlights:
- British Atherosclerosis Society Michael Davies Young Investigator Award (2005)
- British Society for Cardiovascular Research Excellence Prize (2017)
- British Atherosclerosis Society John French Lecturer (2016)
- Fellowship of European Society of Cardiology (2016)
As an educator, Wheatcroft supervises PhD/MD candidates and serves as academic representative for cardiology trainees. His research program, funded by British Heart Foundation, Diabetes UK, MRC, and ERC grants, drives discovery through the Leeds Institute of Cardiovascular and Metabolic Medicine and Multidisciplinary Cardiovascular Research Centre. Current initiatives include therapeutic angiogenesis projects and endothelial regeneration studies.
